Page last updated: 2024-11-03

procainamide and Sepsis

procainamide has been researched along with Sepsis in 2 studies

Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.

Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Freed, JS1
Reiner, MA1
Hickson, B1
Davidson, RJ1
Walker, W1

Reviews

1 review available for procainamide and Sepsis

ArticleYear
Septic complications of procainamide-induced agranulocytosis: report of two cases.
    The Mount Sinai journal of medicine, New York, 1988, Volume: 55, Issue:2

    Topics: Aged; Agranulocytosis; Escherichia coli Infections; Female; Humans; Male; Procainamide; Pseudomonas

1988

Other Studies

1 other study available for procainamide and Sepsis

ArticleYear
Agranulocytosis caused by procainamide.
    Scottish medical journal, 1972, Volume: 17, Issue:5

    Topics: Acute Kidney Injury; Aged; Agranulocytosis; Anemia; Antibodies, Antinuclear; Anuria; Erythropoiesis;

1972